Tinos Therapeutics, Inc.

Biotech Cambridge, MA

About

Issuer

Entity type
Corporation
Jurisdiction
Delaware
Sector
Biotech
Headquarters
Cambridge, MA
Street
700 Main Street
Zip
02139

Offering

Total offering
$4M
Amount sold
$2.3M
First sale
Sep 4, 2025
Min investment
$0
Securities
—
Federal exemption
Rule 506(b)
Investors so far
3

How this filing compares

Ranked #20 of 47 Biotech filings in April 2026 by offering amount.

Median Biotech filing in April 2026: $3M. This offering is 1.3× the median.

Other Massachusetts filings this week: ALPINE TORTILLA HOLDCO, INC., Base Camp Fund, Base Camp Fund II, BROOKDALE INTERNATIONAL PARTNERS, L.P., Cahaba Partners Core Fixed Income Fund

Leadership

Nikolaos Tapinos — Executive Officer (also: Director)

David Karambizi — Executive Officer (also: Director)

Anastasios Polimenakos — Director

Filing details

Tinos Therapeutics, Inc. filed a Form D with the SEC on April 17, 2026.

Other newest Biotech companies

Other newest companies in Massachusetts